Reference
- FLECKENSTEIN A et al.: Zum wirkungsmechanismus nevartiger koronardilatatoren mit gleichzeiig sanerstoff-einsparenden myokard-effekten. Prenylamin und iproveratril. Z. Kreislaufforsch. (1967) 56:716-744
- TRIGGLE DJ et al.: Synthetic organ ligands active at voltage-gated calcium channels. Ann. NY Acad. Sci. (1991) 635:123-138.
- ZERNIG G: Widening potential for Ca2+ channel interaction. Trends Pharmacol. Sci. (1990). 11:38-44.
- CRIADOM et al.: Primary structure of an agonist binding subunit of the nicotinic acetylcholine receptor from bovine adrenal chromaffin cells. Neurochem. Res. (1992) 17:281-287
- LOPEZ MG et al.: The nicotinic acetylcholine receptor of the bovine chromaffin cell, a new target for dihydropyridines. Eur. J. Pharmacol. (1993) 247:199–207.
- KILPATRICK DL et al.: Ion channels and membrane potential in stimulus-secretion coupling in adrenal medulla cells. J. Neurochem. (1981) 36:1245–1255.
- CORCORAN JJ et al.: Inhibition of calcium uptake and catecholamine secretion by methoxyverapamil (D600) in primary cultures of adrenal medulla cells. J. Neurochem. (1983) 40:1106–1109.
- BOEHM S et al.: Methoxyverapamil reduction of nicotine-induced catecholamine receptor currents. Eur. J. Neurosci. (1993) 5:1280–1286.
- GANNA L et al.: Inhibition of nicotinic receptor-mediated responses in bovine chromaffin cells by diltiazem. Br. J. Pharmacol. (1996) 118:1301–1307.
- GIBSON RS et al.: Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction: results of double-blind, randomized, multicenter trial. New Engl. J. Med. (1986) 315:423–429.